Oct 31 2024 18 mins
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol - doi.org/10.3899/jrheum.2024-0400
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study - doi.org/10.3899/jrheum.2024-0053
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries - doi.org/10.3899/jrheum.2024-0252
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study - doi.org/10.3899/jrheum.2024-0298
Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal - doi.org/10.3899/jrheum.2023-1113
Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol - doi.org/10.3899/jrheum.2024-0400
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study - doi.org/10.3899/jrheum.2024-0053
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries - doi.org/10.3899/jrheum.2024-0252
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study - doi.org/10.3899/jrheum.2024-0298
Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal - doi.org/10.3899/jrheum.2023-1113